Therefore, we hypothesized that the fibrinolytic system, previously implicated in the mobilization of hematopoietic stem and progenitor cells12, including ANXA2, have an impact on leukemia progression, possibly via involvement of the natural anticoagulant pathway and ECM remodeling. This evidence concerns the gene ANXA2 and leukemia.